Role of monocyte chemoattractant protein-1 (MCP-1) as an immune-diagnostic biomarker in the pathogenesis of chronic periodontal disease

Cytokine

Volumn 61, Issue 3, 2013, Pages 892-897

  Gupta, Mili ^a   Chaturvedi, Rashi ^a   Jain, Ashish ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Chronic periodontitis; GCF; MCP 1; Saliva; Serum

Indexed keywords

MONOCYTE CHEMOTACTIC PROTEIN 1;

ADULT; ANALYTICAL PARAMETERS; ARTICLE; CHRONIC PERIODONTITIS; CLINICAL ARTICLE; CLINICAL ATTACHMENT LEVEL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GINGIVA INDEX; GINGIVITIS; HUMAN; LONGITUDINAL STUDY; MALE; PATHOGENESIS; PLAQUE INDEX; PREVENTIVE DENTISTRY; PRIORITY JOURNAL; PROBING POCKET DEPTH; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; SALIVA LEVEL; SERODIAGNOSIS; TREATMENT DURATION;

ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHEMOKINE CCL2; CHRONIC PERIODONTITIS; FEMALE; GINGIVAL CREVICULAR FLUID; HUMANS; MALE; MIDDLE AGED; SALIVA;

EID: 84875374042     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.12.012     Document Type: Article

References (48)

1. Fokkema S.J., Loos B.G., van der Velden U. Monocyte-derived RANTES is intrinsically elevated in periodontal disease while MCP-1 levels are related to inflammation and are inversely correlated with IL-12 levels. Clin Exp Immunol 2003, 131:477-483.
2. Kornman K.S., Page R.C., Tonetti M.S. The host response to the microbial challenge in periodontitis: assembling the players. Periodontology 1997, 2000(14):33-53.
3. Gemmell E., Seymour G.J. Immunoregulatory control of Th1/Th2 cytokine profiles in periodontal disease. Periodontology 2004, 2000(35):21-41.
4. Graves D.T. The potential role of chemokines and inflammatory cytokines in periodontal disease progression. Clin Infect Dis 1999, 28:482-490.
5. Baggiolini M. Chemokines in pathology and medicine. J Intern Med 2001, 250:91-104.
6. Zlotnik A., Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 2000, 12:121-127.
7. Silva T.A., Garlet G.P., Fukada S.Y., Silva J.S., Cunha F.Q. Chemokines in oral inflammatory diseases: apical periodontitis and periodontal disease. J Dent Res 2007, 86:306-319.
8. Rossi D., Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 2000, 18:217-242.
9. Colotta F., Borre A., Wang J.M., Tattanelli M., Maddalena F., Polentarutti N., et al. Expression of monocyte chemotactic cytokine by human mononuclear phagocytes. J Immunol 1992, 148:760-765.
10. Yu X., Antoniades H.N., Graves D.T. Expression of monocyte chemoattractant protein-1 in human inflamed gingival tissues. Infect Immun 1993, 61:4622-4628.
11. Yu X., Graves D.T. Fibroblasts, mononuclear phagocytes, and endothelial cells express monocyte chemoattractant protein-1 (MCP-1) in inflamed human gingiva. J Periodontol 1995, 66:80-88.
12. Hanazawa S., Kawata Y., Takeshita A., Kumada H., Okithu M., Tanaka S., et al. Expression of monocyte chemoattractant protein-1 (MCP-1) in adult periodontal disease: increased monocyte chemotactic activity in crevicular fluids and induction of MCP-1 expression in gingival tissues. Infect Immun 1993, 61:5219-5224.
13. Champagne C.M., Buchanan W., Reddy M.S., Preisser J.S., Beck J.D., Offenbacher S. Potential for gingival crevice fluid measures as predictors of risk for periodontal diseases. Periodontology 2003, 2000(31):167-180.
14. Emingil G., Atilla G., Hüseyinov A. Gingival crevicular fluid monocyte chemoattractant protein-1 and RANTES levels in patients with generalized aggressive periodontitis. J Clin Periodontol 2004, 31:829-834.
15. Kurtiş B., Tüter G., Serdar M., Akdemir P., Uygur C., Firatli E., et al. Gingival crevicular fluid levels of monocyte chemoattractant protein-1 and tumor necrosis factor-alpha in patients with chronic and aggressive periodontitis. J Periodontol 2005, 76:1849-1855.
16. Pradeep A.R., Daisy H., Hadge P. Gingival crevicular fluid levels of monocyte chemoattractant protein-1 in periodontal health and disease. Arch Oral Biol 2009, 54:503-509.
17. Paquette D.W., Brodala N., Nichols T.C. Cardiovascular disease, inflammation, and periodontal infection. Periodontology 2007, 2000(44):113-126.
18. Scannapieco F.A. Role of oral bacteria in respiratory infection. J Periodontol 1999, 70:793-802.
19. Mealey B.L., Ocampo G.L. Diabetes mellitus and periodontal disease. Periodontology 2000 2007, 44:127-153.
20. Takeya M., Yoshimura T., Leonard E.J., Takahashi K. Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody. Hum Pathol 1993, 24:534-539.
21. Antoniades H.N., Neville-Golden J., Galanopoulos T., Kradin R.L., Valente A.J., Graves D.T. Expression of monocyte chemoattractant protein-1 mRNA in human idiopathic pulmonary fibrosis. Proc Natl Acad Sci 1992, 89:5371-5375.
22. Graves D.T., Barnhill R., Galanopoulos T., Antoniades H.N. Expression of monocyte chemotactic protein-1 in human melanoma in vivo. Am J Pathol 1992, 140:9-14.
23. Villiger P.M., Terkeltaub R., Lotz M. Production of monocyte chemoattractant protein-1 by inflamed synovial tissue and cultured synoviocytes. J Immunol 1992, 149:722-727.
24. Yu X.H., Barnhill R.L., Graves D.T. Expression of monocyte chemoattractant protein-1 (MCP-1) in delayed type hypersensitivity reactions in the skin. Lab Invest 1994, 71:235-266.
25. Pradeep A.R., Daisy H., Hadge P. Serum levels of monocyte chemoattractant protein-1 in periodontal health and disease. Cytokine 2009, 47:77-81.
26. Miller C.S., King C.P., Langub M.C., Kryscio R.J., Thomas M.V. Salivary biomarkers of existing periodontal disease: a cross-sectional study. J Am Dent Assoc 2006, 137:322-329.
27. Garrett J.S. Effects of non-surgical periodontal therapy on periodontitis in humans: a review. J Clin Periodontol 1983, 510-515.
28. Page R.C., Eke P.I. Case definitions for use in population-based surveillance of periodontitis. J Periodontol 2007, 78:1387-1399.
29. Navazesh M. Methods for collecting saliva. Ann NY Acad Sci 1993, 694:72-77.
30. Choi E.K., Park S.A., Oh W.M., Kang H.C., Kuramitsu H.K., Kim B.G., et al. Mechanisms of porphyromonas gingivalis-induced monocyte chemoattractant protein-1 expression in endothelial cells. FEMS Immunol Med Microbiol 2005, 44:51-58.
31. Griffiths G.S. Formation, collection and significance of gingival crevicular fluid. Periodontology 2003, 2000(31):32-42.
32. Persson G.R., Page R.C. Effect of sampling time and repetition on gingival crevicular fluid and aspartate aminotransferase activity. J Periodontal Res 1990, 25:236-242.
33. Lamster I.B., Harper D., Goldstein S., Celenti R.S., Oshrain R.L. The effect of sequential sampling on crevicular fluid volume and enzyme activity. J Clin Periodontol 1989, 16:252-258.
34. Curtis M.A., Griffiths G.S., Price S.J., Coulthurst S.K., Johnson N.W. The total protein concentration of gingival crevicular fluid. Variation with sampling time and gingival inflammation. J Clin Periodontol 1988, 15:628-632.
35. Papapanagiotou D., Nicu E.A., Bizzarro S., et al. Periodontitis is associated with platelet activation. Atherosclerosis 2009, 202:605-611.
36. Herzberg M.C., Weyer M.W. Dental plaque, platelets and cardiovascular disease. Ann Periodontol 1998, 3:151-160.
37. Tanaka T., Nakamura Y., Nasuno A., Mezaki T., Higuchi K., Fukunaga H., et al. Plasma concentrations of monocyte chemoattractant protein-1 (MCP-1) and neopterin in the coronary circulation of patients with coronary artery disease. Circ J 2004, 68:114-120.
38. Gonzalez-Quesada C., Frangogiannis N.G. Monocyte chemoattractant protein (MCP-1)/CCL2 as a biomarker in acute coronary syndromes. Curr Atheroscler Rep 2009, 11:131-138.
39. Zhang L., Henson B.S., Camargo P.M. The clinical value of salivary biomarkers for periodontal disease. Periodontology 2009, 2000(51):25-37.
40. Sexton W.M., Lin Y., Kryscio R.J., Dawson D.R., Ebersole J.L., Miller C.S. Salivary biomarkers of periodontal disease in response to treatment. J Clin Periodontol 2011, 38:434-441.
41. Nomura Y., Shimada Y., Hanada N., Numabe Y., Kamoi K., Sato T., et al. Salivary biomarkers for predicting the progression of chronic periodontitis. Arch Oral Biol 2012, 57:413-420.
42. Teles R.P., Likhari V., Socransky S.S., Haffajee A.D. Salivary cytokine levels in chronic periodontitis and periodontally healthy subjects. A cross-sectional study. J Periodontal Res 2009, 44:411-417.
43. Freitas C.O., Gomes-Filho I.S., Naves R.C., Noqueira Filho Gda R., Cruz S.S., Santos C.A., et al. Influence of periodontal therapy on C-reactive protein level: a systematic review and meta-analysis. J Appl Oral Sci 2012, 20:1-8.
44. Matsui K., Ikeda U., Murakami Y., Yoshioka T., Shimada K. Intravenous prostaglandin E1 reduces monocyte chemoattractant protein-1 levels in peripheral arterial obstructive disease. Am Heart J 2003, 145:330-333.
45. Furukawa Y., Matsumori A., Ohashi N., Shioi T., Ono K., Harada A., et al. Anti-monocyte chemoattractant protein-1/monocyte chemotactic and activating factor antibody inhibits neointimal hyperplasia in injured rat carotid arteries. Circ Res 1999, 84:306-311.
46. Yue Y., Gui J., Xu W., Xiong S. Gene therapy with CCL2 (MCP-1) mutant protects CVB-3 induced myocarditis by compromising Th1 polarisation. Mol Immunol 2011, 48:706-713.
47. Nakamura Y., Yamada Y., Shimomura H., Nagayoshi Y., Tsujita K., Yamashita T., et al. Effect of edaravone on plasma monocyte chemoattractant protein-1 levels in patients with acute myocardial infarction. J Cardiol 2009, 54:416-424.
48. Yang Y.P., Dong Q.L., Zhang X.H., Zhang Y.H., Zhu L., Li S.Y., et al. Combination of fluvastatin and losartan relieves atherosclerosis and macrophage infiltration in atherosclerotic plaques in rabbits. Acta Pharmacol Sin 2011, 32:1259-1265.